[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354226-105":59,"doc-detail-354226-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hyperglycaemia-induced-metabolic-stress-promotes-emt-driven-therapeutic-resistance-evidence-of-a-deleterious-feed-forward-cycle","Hyperglycaemia-Induced Metabolic Stress Promotes - EMT-Driven Therapeutic Resistance - Evidence of a Deleterious Feed-Forward Cycle","","The phenotypic plasticity of epithelial cells along the epithelial–mesenchymal (E–M) axis, or epithelial–mesenchymal transition (EMT), drives tumour progression and therapeutic resistance. This review examines how hyperglycaemia-induced metabolic stress may interact with EMT to sustain resistance. It consolidates mechanistic evidence involving transcription factors, signalling pathways, growth factors, integrins and matrix metalloproteinases, and highlights EMT hybrid states with enhanced metastatic and metabolic features. Mechanistically, elevated glucose increases ROS, activates EMT transcriptional programs and shifts metabolism toward glycolysis, supporting drug efflux and mesenchymal maintenance. Clinical data associate hyperglycaemia in OSCC with more advanced stages, poorer outcomes and higher recurrence and metastasis, while validation is still needed in prospective interventional studies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hyperglycaemia-induced-metabolic-stress-promotes-emt-driven-therapeutic-resistance-evidence-of-a-deleterious-feed-forward-cycle/354226/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hyperglycaemia-induced-metabolic-stress-promotes-emt-driven-therapeutic-resistance-evidence-of-a-deleterious-feed-forward-cycle/354226.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does EMT play in tumour progression and therapeutic resistance?","Question",{"text":112,"@type":113},"EMT is linked to tumour progression and resistance because epithelial cells progressively acquire mesenchymal traits that support metastasis, fibrosis, and aggressive disease behavior.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does hyperglycaemia contribute to EMT-driven therapeutic resistance?",{"text":117,"@type":113},"Elevated glucose increases reactive oxygen species (ROS), activates EMT-promoting transcription factors, and shifts metabolism toward glycolysis. These changes can create feed-forward loops that support drug efflux and help maintain mesenchymal phenotypes.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence links hyperglycaemia to worse cancer outcomes, and which cancer types show the strongest support?",{"text":121,"@type":113},"Clinical data indicate that hyperglycaemia in OSCC patients correlates with more advanced tumour stages, longer hospital stays, less effective treatments, and higher local recurrence and distant metastasis rates. The strongest clinical evidence is in oral squamous cell carcinoma, supported by data from pancreatic and breast cancers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354226,1790388568,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Review  \nHyperglycaemia-Induced Metabolic Stress Promotes  \nEMT-Driven Therapeutic Resistance in Cancer: Evidence of a Deleterious Feed-Forward Cycle  \nRabia Zafar 1, Thanh Dat Pham 1, Lupeuea Vakafua 1, Teana Reed 1 and Naisana Seyedasli 1,2, *  \nAcademic Editor: Kevin G. Chen  \nReceived: 4 March 2026  \nRevised: 25 April 2026  \nAccepted: 11 May 2026  \nPublished: 14 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Westmead Hospital, Westmead, NSW 2145, Australia  \n2 Centre for Cancer Research, The Westmead Institute for Medical Research, Westmead, NSW 2145, Australia  \n* [Correspondence: naisana.seyedasli@sydney.edu.au](Correspondence: naisana.seyedasli@sydney.edu.au)  \nAbstract  \nThe phenotypic plasticity of epithelial cells along the epithelial–mesenchymal (E-M) axis, or epithelial–mesenchymal transition (EMT), is a critical aspect of tumour progression and therapeutic resistance. During EMT, epithelial cells gradually acquire mesenchymal traits, facilitating vital functions in embryogenesis, wound healing, fibrosis, and tumour metastasis. This review article investigates the potential interplay between hyperglycaemiainduced metabolic stress and EMT in the context of therapeutic resistance. The study examines a complex, multifaceted network of molecular mechanisms regulating EMT, including specialised transcription factors and signalling pathways as well as growth factors, integrins, and matrix metalloproteinases in various epithelial carcinomas. Emerging findingshave demonstrated the existence of EMT hybrid states along the continuum, possessing heightened metastatic potential and distinctive metabolic signatures that play critical roles in the development of therapeutic resistance in cancer cells. Hyperglycaemia has been particularly highlighted for its potential to promote EMT-driven therapeutic resistance through various interconnected mechanisms. Elevated glucose levels induce the increased production of reactive oxygen species (ROS), activation of EMT-promoting transcription factors, and a metabolic shift towards glycolysis. This hyperglycaemic stress involves upregulation of glucose transporters and glycolytic enzymes, creating feed-forward loops that support drug efflux mechanisms and help maintain the mesenchymal phenotype. Clinical data also indicate that hyperglycaemia in OSCC patients is associated with more advanced tumour stages, more extended hospital stays, less effective treatments, and higher rates of local recurrence and distant metastasis. Overall, these insights reveal a deleterious feed-forward loop in which hyperglycaemia promotes EMT-driven therapeutic resistance, with the strongest clinical evidence in oral squamous cell carcinoma (OSCC) and supportive data from pancreatic and breast cancers. Although glycaemic control represents a promising low-risk adjunctive approach, its clinical benefit remains to be validated in prospective interventional studies.  \nKeywords: epithelial–mesenchymal transition (EMT); hyperglycaemia; metabolic stress; therapeutic resistance; cancer; carcinoma  \n1. Introduction  \nThe multifactorial transition of epithelial cells into mesenchymal cells is a process known as epithelial–mesenchymal transition (EMT), often characterised by the loss of cell  \nadhesion and increased cell mobility [1,2] . It is a progressive and dynamic change in the cellular organisation of epithelial cells, in which they lose epithelial properties while acquiring the behaviours and phenotypes associated with mesenchymal cells [1,2] . Acquiring a mesenchymal phenotype enables cells to migrate to distant organs, maintain their stemness, and differentiate into multiple cell types, thereby initiating processes such as wound healing, metastasis, and fibrosis [","cbCailGQMFhAFk3b","https://ap.wps.com/l/cbCailGQMFhAFk3b","pdf",1857539,28,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What role does EMT play in tumour progression and therapeutic resistance?\",\"answer\":\"EMT is linked to tumour progression and resistance because epithelial cells progressively acquire mesenchymal traits that support metastasis, fibrosis, and aggressive disease behavior.\"},{\"question\":\"How does hyperglycaemia contribute to EMT-driven therapeutic resistance?\",\"answer\":\"Elevated glucose increases reactive oxygen species (ROS), activates EMT-promoting transcription factors, and shifts metabolism toward glycolysis. These changes can create feed-forward loops that support drug efflux and help maintain mesenchymal phenotypes.\"},{\"question\":\"What evidence links hyperglycaemia to worse cancer outcomes, and which cancer types show the strongest support?\",\"answer\":\"Clinical data indicate that hyperglycaemia in OSCC patients correlates with more advanced tumour stages, longer hospital stays, less effective treatments, and higher local recurrence and distant metastasis rates. The strongest clinical evidence is in oral squamous cell carcinoma, supported by data from pancreatic and breast cancers.\"}]","Hyperglycaemia-Induced Metabolic Stress Promotes - EMT-Driven Therapeutic Resistance - Evidence of a Deleterious Feed-Forward Cycle | PDF",1790109629,71,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81b115c38f1b2a2e9bb3daeffafd0112.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9df50478a9c24dbb16c171575ee6dd18.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14259809b9bb465262314beeb7fa3afa.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5a33ec2faf0d8c60ab1cbef1b9f9131.webp",980,1385]